CINIE CINIE
中文 | English | Français | Русский
Home CINIE World Nuclear Fusion Nuclear Application

Search Results

Keyword:PSMA-targeted radiopharmaceuticals

Institute of Radiation Medicine, Chinese Academy of Medical Sciences Hosts Academic Seminar on PSMA-Targeted Radiopharmaceuticals

Institute of Radiation Medicine, Chinese Academy of Medical Sciences Hosts Academic Seminar on PSMA-Targeted Radiopharmaceuticals

On August 3, the Institute of Radiation Medicine, Chinese Academy of Medical Sciences held an academic seminar, inviting Professor Lin Guoxian from the BC Cancer Agency in Vancouver, Canada, to deliver a lecture titled "Development of Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals for the Diagnosis and Treatment of Prostate Cancer." The seminar was held in a hybrid format, with some researchers and graduate students from the institute attending in person. Professor Lin Guoxian has long been engaged in the development of targeted radiopharmaceuticals for cancer diagnosis and therapy, having led or contributed to the publication of over 135 peer-reviewed journal articles, filed more than 30 patent applications related to radiopharmaceuticals, and completed clinical translation of 7 self-developed radiopharmaceuticals applied in...

2026-08-07

Reading Ranking

  • 1 US Department of Energy Study Shows: Deep Borehole Disposal Option Can Significantly Reduce Nuclear Fuel Cycle Back-End Waste Disposal Costs
  • 2 Mao Yawei, General Manager of China Zhongyuan Engineering Corporation, Leads a Delegation to Visit Harbin Engineering University
  • 3 U.S. Research Reveals Diamond Melting Mechanism at High Pressure, Potentially Enhancing Inertial Confinement Fusion Performance
  • 4 Palisades Nuclear Power Plant Restart Suspended Due to Fuel Assembly Issue
  • 5 The "Weaponized" Nuclear Power Plant: Dual Narratives and Governance Dilemmas in the Zaporizhzhia Nuclear Crisis
  • 6 Israel's nT-TaO Signs Memorandum of Understanding with US-based Orion to Explore Deployment of Compact Fusion Systems for Data Center Power Supply
  • 7 Guoke Ion Makes Its Debut at AOCMP 2026, Domestic Ion Therapy Technology Draws Attention from Asia-Pacific Peers
  • 8 Hangzhou Puxi Guangjing Semiconductor Technology Co., Ltd. Completes C Round Financing of Several Hundred Million Yuan
  • 9 US Delivers Cold War-Era Reactor Molten Salt Coolant to Texas Nuclear Innovation Project
  • 10 Large-area pixel detector independently developed by the Institute of High Energy Physics, Chinese Academy of Sciences completes long-term online operation validation
  • 11 CNNC High Energy Seminar Focuses on Quality Control of Domestic Radiotherapy Equipment, Multiple Parties Join Hands to Build Industry Standards
  • 12 Nova Fusion and Fuyao University of Science and Technology Jointly Established Fusion Innovation Research Institute and Innovation Laboratory Unveiled
  • 13 IAEA Launches New Project to Advance Research Network on Small and Medium-Sized Fusion Devices
  • 14 Turkey's National Nuclear Energy Agency (TUNAS) and the U.S. Trade and Development Agency (USTDA) Launch New Nuclear Energy Cooperation
  • 15 Leshan Accelerates Construction of Medical Isotope Production Base to Promote Domestic Substitution of "Anti-Cancer Nuclear Drugs"
CINIE

Organizing Committee of the Shenzhen Nuclear Expo

Telephone: +86 10-67808008

+86 10-68808008

Email: info@cinie.net

CINIE

Event Overview News Center Support Services Highlights Archive Contact Us

World Nuclear

China Nuclear Power News World Nuclear Power News Expert Views Nuclear Power Technology

Fusion

China Fusion World Fusion Big Science Facilities ITER Program Business & Capital

Nuclear Application

Medical Scientific Research Environmental Protection Industry Food Agriculture Security
About us | All rights reserved
CINIE All rights reserved 2026 ICP License:京ICP备12027382号-9